Biobizkaia
Centro de investigación
GlaxoSmithKline (Spain)
Madrid, EspañaPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (Spain) (10)
2021
-
Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study (Drugs, (2021), 81, 15, (1763-1774), 10.1007/s40265-021-01597-9)
Drugs
-
REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study
Drugs, Vol. 81, Núm. 15, pp. 1763-1774
2010
-
Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)
Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959
2009
-
Impact of acute otitis media pathogen shifts on the clinical efficacy of several antibiotics: A therapeutic outcomes model
Journal of Chemotherapy, Vol. 21, Núm. 4, pp. 408-413
2008
-
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens
HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313
2007
-
Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD)
Journal of Affective Disorders, Vol. 102, Núm. 1-3, pp. 93-99
-
The sufficiency of the HAM-D6 as an outcome instrument in the acute therapy of antidepressants in the outpatient setting
International Journal of Psychiatry in Clinical Practice, Vol. 11, Núm. 2, pp. 146-150
-
What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model
Journal of Antimicrobial Chemotherapy, Vol. 60, Núm. 3, pp. 605-612
2003
-
Evaluación psicométrica comparativa de las versiones en español de 6, 17 y 21 ítems de la Escala de valoración de Hamilton para la evaluación de la depresión
Medicina Clinica, Vol. 120, Núm. 18, pp. 693-700
-
Validación de las versiones en español de la Clinical Anxiety Scale y del Physician Questionnaire para la evaluación de los trastornos de ansiedad
Medicina Clinica, Vol. 121, Núm. 10, pp. 367-374